Hanieh Barghchi

Hanieh Barghchi

Auto-generated profile, based on publicly available information

Hanieh Barghchi

Department of Nutrition Sciences, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 99199-91766, Iran

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2023 in Food Science & Nutrition
Verified
Journal Article
Open access
ZDZahra Dehnavi
Zahra Dehnavi
HBHanieh Barghchi
Hanieh Barghchi
AEAli Jafarzadeh Esfehani
Ali Jafarzadeh Esfehani
MBMehdi Barati
Mehdi Barati
ZKZahra Khorasanchi
Zahra Khorasanchi
MSMohammadq Safarian
Mohammadq Safarian
Dietary proteins have been shown to stimulate thermogenesis, increase satiety, and improve insulin sensitivity in the short and long term. Animal‐based proteins (AP) and plant‐based proteins (PP) have different amino acid profiles, bioavailability, and digestibility, so it seems to have various short‐ and long‐term effects on metabolic responses. This review aimed to compare the findings of controlled clinical trials on postprandial effects of dietary Aps versus PPs on energy expenditure (EE), lipemia, glycemia, and insulinemia. Data are inconclusive regarding the postprandial effects of APs and PPs. However, there is some evidence indicating that APs increase postprandial EE, DIT, and SO more than PPs. With lipemia and glycemia, most studies showed that APs reduce or delay postprandial glycemia and lipemia and increase insulinemia more than PPs. The difference in amino acid composition, digestion and absorption rate, and gastric emptying rate between APs and PPs explains this difference.

1 January 2023 in Clinical Nutrition Research
Verified
Journal Article
Open access
PDF file
MDMonireh Dahri
Monireh Dahri
ASAtefeh Sarafan Sadeghi
Atefeh Sarafan Sadeghi
NPNaseh Pahlavani
Naseh Pahlavani
ENElyas Nattagh
Elyas Nattagh
MHMazyar Hashemilar
Mazyar Hashemilar
ATAli Tarighat-Esfanjani
Ali Tarighat-Esfanjani
Dahri M, et al. Clin Nutr Res. 2023 Oct;12(4):257-268. https://doi.org/10.7762/cnr.2023.12.4.257

28 March 2023 in Food Science & Nutrition
Verified
Journal Article
Open access
STSaeedeh Talebi
Saeedeh Talebi
ADAndrew S. Day
Andrew S. Day
MSMahammad Safarian
Mahammad Safarian
SSSeyed Javad Sayedi
Seyed Javad Sayedi
MJMahmood Reza Jaafari
Mahmood Reza Jaafari
HKHamid Reza Kianifar
Hamid Reza Kianifar
Inflammation may develop due to internal dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) protein or external factors in patients with cystic fibrosis (CF). This prospective randomized clinical trial aimed to ascertain the effects of nano‐curcumin as an anti‐inflammatory agent and a CFTR modulator on clinical and inflammatory markers in children with CF. Children with CF were randomly assigned to receive daily curcumin or a placebo for 3 months. The primary outcome measure was to evaluate inflammatory indices, nasopharyngeal swab analysis, and clinical assessments via spirometry, anthropometric measurements, and quality of life (QOL) analysis. Sixty children were included. Intra‐group changes comparison showed that curcumin decreased the level of high‐sensitivity C‐reactive protein (hs‐CRP) (median: −0.31 mg/L, IQR: −1.53 to 0.81; p = .01) and fecal calprotectin level (−29 μg/g, −57.5 to 11.5; p = .03), also increased the level of interleukin (IL)‐10 (6.1 pg/mL, 4.5–9; p = .01). Moreover, curcumin improved the overall QOL and the subscales of the questionnaire. Inter‐group changes comparison depicted the number of Pseudomonas colonies reduced by about 52% in the curcumin group and gained weight by about 16% (p > .05). Nano‐curcumin seems to be considered as an effective nutritional supplement on hs‐CRP, IL‐10, fecal calprotectin levels, and improving QOL in patients with CF.

1 January 2021 in Clinical Nutrition Research
Verified
Journal Article
Open access
PDF file
AOAndisheh Norouzian Ostad
Andisheh Norouzian Ostad
HBHanieh Barghchi
Hanieh Barghchi
AJAli Jangjoo
Ali Jangjoo
GRGolnaz Ranjbar
Golnaz Ranjbar
RRReza Rezvani
Reza Rezvani
MNMohsen Nematy
Mohsen Nematy
Ostad AN, et al. Clin Nutr Res. 2021 Oct;10(4):341-352. https://doi.org/10.7762/cnr.2021.10.4.341

22 July 2024 in Trials
Verified
Journal Article
Open access
PDF file
AYAliyeh Ghannadzadeh Yazdi
Aliyeh Ghannadzadeh Yazdi
MMMohammad Masoumvand
Mohammad Masoumvand
Elena PhilippouElena Philippou
Elena Philippou
AHAlireza Hatami
Alireza Hatami
ZDZahra Dehnavi
Zahra Dehnavi
MNMohsen Nematy
Mohsen Nematy
Background: Time-restricted eating (TRE) has been shown to be associated with improvements in some aspects of the metabolic syndrome. Nevertheless, only a few studies have addressed the effect of TRE on pulse wave velocity (PWV). We thus propose a randomized controlled trial to compare the effects of TRE with standard dietary advice on PWV and thereby present the protocol. Methods: Forty-eight participants will be assigned to either TRE or control groups using simple randomization. The TRE group will consume their meals during a 10-h period and experience 14 h of fasting. They will also be advised to consume their last meal no later than 20:00. Both groups will receive standard dietary advice. The participants will be followed for 6 weeks. The primary outcome will be changes in PWV. Laboratory measurements, including lipid profile, liver enzyme tests, fasting blood glucose (FBG), insulin concentrations, and insulin resistance, as well as anthropometric data, blood pressure, basal metabolic rate, appetite status, physical activity level, sleep quality, cognitive function, quality of life, and calorie intake, will be evaluated throughout the study. Discussion: The outcomes of this study will allow a comparison of the effects of TRE and standard dietary recommendations on PWV and other cardiometabolic factors in individuals with metabolic syndrome (MetS). Trial registration: Iranian Registry of Clinical Trials; code: IRCT20201230049889N1; registered on August 14, 2022. The registration of the trial is accessible at: https://www.IRCT.ir/trial/64485?revision=281341.

1 January 2025 in Clinical Nutrition Research
Verified
Journal Article
Open access
PDF file
HBHanieh Barghchi
Hanieh Barghchi
AAAsie Araste
Asie Araste
NVNaeimeh Varasteh
Naeimeh Varasteh
ZDZahra Dehnavi
Zahra Dehnavi
RZReza Zare-Feyzabadi
Reza Zare-Feyzabadi
MGMajid Ghayour-Mobarhan
Majid Ghayour-Mobarhan
Barghchi H, et al. Clin Nutr Res. 2025 Jan;14(1):17-29. https://doi.org/10.7762/cnr.2025.14.1.17